Antidepressants attenuate the dexamethasone-induced decrease in viability and proliferation of human neuroblastoma SH-SY5Y cells: A involvement of extracellular regulated kinase (ERK1/2)

[1]  W. Suwanjang,et al.  Melatonin attenuates dexamethasone toxicity-induced oxidative stress, calpain and caspase activation in human neuroblastoma SH-SY5Y cells , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  W. Lasoń,et al.  The Extent of Neurodegeneration and Neuroprotection in Two Chemical In Vitro Models Related to Parkinson’s Disease is Critically Dependent on Cell Culture Conditions , 2013, Neurotoxicity Research.

[3]  M. Leśkiewicz,et al.  Stimulatory effect of antidepressant drug pretreatment on progression of B16F10 melanoma in high-active male and female C57BL/6J mice , 2011, Journal of Neuroimmunology.

[4]  C. Tasca,et al.  Neurotoxicity induced by dexamethasone in the human neuroblastoma SH-SY5Y cell line can be prevented by folic acid , 2011, Neuroscience.

[5]  P. Rhodes,et al.  Dexamethasone pre-treatment protects brain against hypoxic-ischemic injury partially through up-regulation of vascular endothelial growth factor A in neonatal rats , 2011, Neuroscience.

[6]  Q. Lian,et al.  Quantitative proteomic analysis of dexamethasone-induced effects on osteoblast differentiation, proliferation, and apoptosis in MC3T3-E1 cells using SILAC , 2011, Osteoporosis International.

[7]  D. Salomonczyk,et al.  Development and Validation of a Screening Assay for the Evaluation of Putative Neuroprotective Agents in the Treatment of Parkinson’s Disease , 2011, Neurotoxicity Research.

[8]  Zhijun Zhang,et al.  Fluoxetine attenuates the inhibitory effect of glucocorticoid hormones on neurogenesis in vitro via a two-pore domain potassium channel, TREK-1 , 2011, Psychopharmacology.

[9]  G. Rajkowska,et al.  The New Inhibitor of Monoamine Oxidase, M30, has a Neuroprotective Effect Against Dexamethasone-Induced Brain Cell Apoptosis , 2010, Front. Neurosci..

[10]  Fabio Klamt,et al.  Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies , 2010, Brain Research.

[11]  Hong-rong Xie,et al.  SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. , 2010, Chinese medical journal.

[12]  William R Mundy,et al.  Neuronal models for evaluation of proliferation in vitro using high content screening. , 2010, Toxicology.

[13]  John F. Cryan,et al.  “Killing the Blues”: A role for cellular suicide (apoptosis) in depression and the antidepressant response? , 2009, Progress in Neurobiology.

[14]  E. Obuchowicz,et al.  Antiapoptotic and neurotrophic effects of antidepressants: A review of clinical and experimental studies , 2009, Brain Research Bulletin.

[15]  G. Vinson.  The adrenal cortex and life , 2009, Molecular and Cellular Endocrinology.

[16]  Shawna K. Tazik,et al.  Comparative Neuroprotective Effects of Rasagiline and Aminoindan with Selegiline on Dexamethasone-Induced Brain Cell Apoptosis , 2009, Neurotoxicity Research.

[17]  E. Klein,et al.  Norepinephrine-glucocorticoids interaction does not annul the opposite effects of the individual treatments on cellular plasticity in neuroblastoma cells. , 2008, European journal of pharmacology.

[18]  M. Leśkiewicz,et al.  Excitatory neurosteroids attenuate apoptotic and excitotoxic cell death in primary cortical neurons. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[19]  M. Regulska,et al.  Effects of neurosteroids on hydrogen peroxide‐ and staurosporine‐induced damage of human neuroblastoma SH‐SY5Y cells , 2008, Journal of neuroscience research.

[20]  M. Glaser,et al.  Neuroprotection and enhancement of remyelination by estradiol and dexamethasone in cocultures of rat DRG neurons and Schwann cells , 2008, Brain Research.

[21]  M. Regulska,et al.  The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells , 2008, Neurochemistry International.

[22]  S. Scheggi,et al.  Hypothalamus–pituitary–adrenal modifications consequent to chronic stress exposure in an experimental model of depression in rats , 2007, Neuroscience.

[23]  R. Burke.  Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease. , 2007, Pharmacology & therapeutics.

[24]  J. Macher,et al.  Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: Dopaminergic, noradrenergic and thyroid correlates , 2006, Psychoneuroendocrinology.

[25]  Li-Hsin Chen,et al.  Moclobemide upregulated Bcl‐2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular‐regulated kinase pathway , 2006, British journal of pharmacology.

[26]  B. Roozendaal,et al.  Do Corticosteroids Damage the Brain? , 2006, Journal of neuroendocrinology.

[27]  D. Swaab,et al.  The stress system in the human brain in depression and neurodegeneration , 2005, Ageing Research Reviews.

[28]  K. Felszeghy,et al.  Dexamethasone Downregulates Chemokine Receptor CXCR4 and Exerts Neuroprotection against Hypoxia/Ischemia-Induced Brain Injury in Neonatal Rats , 2004, Neuroimmunomodulation.

[29]  H. Tähti,et al.  Modulation of glucose uptake in glial and neuronal cell lines by selected neurological drugs. , 2004, Toxicology letters.

[30]  M. Hetman,et al.  Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. , 2004, European journal of biochemistry.

[31]  A. Compston,et al.  Decreased iNOS synthesis mediates dexamethasone‐induced protection of neurons from inflammatory injury in vitro , 2003, The European journal of neuroscience.

[32]  R. Kerwin,et al.  Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters , 2003, British journal of pharmacology.

[33]  F. Holsboer,et al.  Antidepressants Differentially Influence the Transcriptional Activity of the Glucocorticoid Receptor in vitro , 2003, Neuroendocrinology.

[34]  G. Rabinovich,et al.  Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment , 2003, Psychoneuroendocrinology.

[35]  M. Mikuni,et al.  Modulation of the human glucocorticoid receptor function by antidepressive compounds , 2003, Neuroscience Letters.

[36]  C. Crochemore,et al.  Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  Angela L. Lee,et al.  Stress and depression: possible links to neuron death in the hippocampus. , 2002, Bipolar disorders.

[38]  R. Kerwin,et al.  Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters , 2001, British journal of pharmacology.

[39]  G. Rajkowska,et al.  Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells , 2000, Biological Psychiatry.

[40]  B. Budziszewska,et al.  Antidepressant drugs inhibit glucocorticoid receptor‐mediated gene transcription – a possible mechanism , 2000, British journal of pharmacology.

[41]  S. Swendeman,et al.  The effects of serum depletion and dexamethasone on growth and differentiation of human neuroblastoma cell lines. , 2000, Journal of pediatric surgery.

[42]  M. Matzuk,et al.  Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. , 1999, The Journal of pharmacology and experimental therapeutics.

[43]  C. Pariante,et al.  Steroid-Independent Translocation of the Glucocorticoid Receptor by the Antidepressant Desipramine , 1997 .

[44]  F. Holsboer,et al.  Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. , 1995, Neuroendocrinology.

[45]  H. Griffiths,et al.  Suitability of B65 and SH-SY5Y neuroblastoma cells as models for 'in vitro' neurotoxicity testing. , 1993, Biochemical Society transactions.

[46]  B. McEwen,et al.  Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: Implications for the dexamethasone suppression test , 1992, Biological Psychiatry.

[47]  Robert M. Sapolsky,et al.  Stress, the Aging Brain, and the Mechanisms of Neuron Death , 1992 .

[48]  B. McEwen,et al.  The Vulnerability of the Hippocampus to Protective and Destructive Effects of Glucocorticoids in Relation to Stress , 1992, British Journal of Psychiatry.